FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG SELF TEST 2CT

MDR report key: 17977381 · Received October 20, 2023

Report

Report Number
1221359-2023-01565
Event Type
Malfunction
Date Received
October 20, 2023
Date of Event
October 4, 2023
Report Date
November 21, 2023
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
UDI-DI
00811877011408
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

D4: UDI (B)(4). TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 221038 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER KIT PART NUMBER 195-160 / LOT 221038 AND DEVICE PART NUMBER 195-430H / LOT 217299. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. THE CURRENT OVERALL INCIDENT RATE FOR FALSE NEGATIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) FOR LOT 221038 BASED ON THE TOTAL QUANTITY OF DEVICES DISTRIBUTED IS (B)(4). IN CONCLUSION, ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER, IT COULD POSSIBLY BE RELATED TO ISSUES INCLUDING THE SELF-TEST USER PERFORMANCE, INTERPRETATION OF THE RESULT, OR THE SPECIFIC PATIENT SAMPLE.G3 DATE RECEIVED BY MFG. 08NOV2023 H3 OTHER TEXT : OTHER - DEVICE NOT RETURNED; SINGLE USE DEVICE.

Additional Manufacturer Narrative · 0

D4: (B)(4). THE REMAINDER OF THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION. H3 OTHER TEXT: OTHER - DEVICE NOT RETURNED; SINGLE USE DEVICE.

Additional Manufacturer Narrative · 0

D4: UDI (B)(4). THE INVESTIGATION REMAINS IN PROGRESS. A SUPPLEMENTAL REPORT WILL BE PROVIDED AFTER COMPLETION.B3; B5; E1 - COUNTRY. OTHER - DEVICE NOT RETURNED; SINGLE USE DEVICE.

Description of Event or Problem · 0

THE CONSUMER REPORTED EIGHT (8) FALSE NEGATIVE RESULTS AMONG THREE (3) CONSUMERS WITH THE BINAXNOW COVID-19 SELF-TEST PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF EIGHT (8); CONSUMER ONE (1) OF THREE (3). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 SELF-TEST PERFORMED ON (B)(6) 2023 ON A NASAL SWAB. ADDITIONAL TESTING WAS PERFORMED WITH A QUICKVIEW ANTIGEN TEST GENERATING A POSITIVE RESULT ON AN UNKNOWN DATE. THE CONSUMER CONFIRMED THERE WAS NO HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CONSUMER CONFIRMED THERE WAS NO DELAY OR IMPACT TO THEIR TREATMENT.

Description of Event or Problem · 0

THE CONSUMER REPORTED TWO FALSE NEGATIVE RESULTS ON A BINAXNOW COVID-19 SELF-TEST PERFORMED ON (B)(6) 2023 USING A NASAL SWAB. THIS REPORT IS FOR TEST ONE (1) OF TWO (2). PREVIOUS TESTING WAS PERFORMED TWICE ON (B)(6) 2023 USING AN UNKNOWN ANTIGEN TEST GENERATING TWO POSITIVE RESULTS. THE CONSUMER CONFIRMED THERE WAS NO HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CONSUMER CONFIRMED THERE WAS NO DELAY OR IMPACT TO THEIR TREATMENT.

Description of Event or Problem · 0

THE CONSUMER REPORTED EIGHT (8) FALSE NEGATIVE RESULTS AMONG THREE (3) CONSUMERS WITH THE BINAXNOW COVID-19 SELF-TEST PERFORMED ON VARIOUS DATES. THIS MFR. REPORT ADDRESSES TEST ONE (1) OF EIGHT (8); CONSUMER ONE (1) OF THREE (3). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH THE BINAXNOW COVID-19 SELF-TEST PERFORMED ON (B)(6) 2023 ON A NASAL SWAB. ADDITIONAL TESTING WAS PERFORMED WITH A QUICKVIEW ANTIGEN TEST GENERATING A POSITIVE RESULT ON AN UNKNOWN DATE. THE CONSUMER CONFIRMED THERE WAS NO HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CONSUMER CONFIRMED THERE WAS NO DELAY OR IMPACT TO THEIR TREATMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1121804 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC. 221038 00811877011408

Patients

Seq Age Sex Outcome Treatment
1 50 YR Female